GNUR 294 EXAM 2 REVIEW (M7-13)
MODULE 7
Pharmacotherapy during Pregnancy
Quick facts:
Teras = Greek word meaning “monster”
Teratogenesis = “to produce a monster”
Teratogens – adverse affects in pregnancy
Effects structural formation in fetal tissue
Effects organ function in fetal tissue
Causes fetal demise
2 individuals of concern:
1) Pregnant women
2) Fetus
Fetal-placental barrier – not effective, many drug molecules can cross and cause harm
to fetus
Adverse effects in pregnant women – causes harm to fetus
Ex: on antihypertensive, dose was too large BP ￬ dramatically ￬ tissue
perfusion fetus experiences same effects
Stages of Fetal Development
3 stages:
1) Preimplantation period – 1-2 weeks of pregnancy before implantation, “all or
none” period, women don’t know they are pregnant at this time
Exposure to teratogen at this stage:
o Death
o No effect at all
2) Embryonic period – 3-8 weeks, point of maximum sensitivity, all structures
are being developed
Exposure to teratogen at this stage:
o Structural abnormalities
3) Fetal period - 9-40 weeks or until birth
Exposure to teratogen at this stage:
o Effects organ functions
Drug Use during Pregnancy
3 reasons:
1) Treatment of pre-existing illness – more women are waiting until older age to
have children
Chronic disease may develop as age progresses – DM, HTN, etc.
Evaluate each risk of classification of drug
o Drug/dose can be changed during pregnancy to ￬ risk
2) Treatment of complications related to pregnancy
, Develops chronic disease during pregnancy – gestational DM, HTN, etc.
3) Treatment of conditions unrelated to pregnancy
Develops infection during pregnancy
Nurse’s role – main consideration to determine which drug to prescribe – think about pt
condition w/ perspective to how it effects the fetus
Pregnancy test – consider any women of child bearing age to potentially be pregnant
when/if admin drug that is highly teratogenic
Pharmacokinetics during Pregnancy
Absorption – due to hormonal changes
￬ GI motility – affects absorption in GI
￬ gastric emptying – affects absorption in GI
￪ HCl production – affects absorption of drugs that are acidic/base
Nausea/vomiting – affects whether or not PO drugs can be kept down
Distribution – total body water ￪ by 50% to help perfuse fetal tissue hemodilution of
protein stores highly protein bound drugs needs to be adjusted
￪ HR ￪ perfusion to fetus
Metabolism – as fetal tissue grows CYP450 enzyme system starts to work fetal tissues
metabolize drug molecules subtherapeutic levels adjust dose
Excretion – potential effects of teratogenic become more concentrated caused by ￪ BF to fetus
Pregnancy Categories – categorizes risk category of many types of drugs that are administered
to an adult pt
5 categories:
1) A – encouraged to take these drugs during pregnancy
2) B – safe in 1st and 2nd trimester
3) C - ￪ risk during pregnancy
4) D – effects organ function, almost never used in pregnancy BUT benefits
could outweigh risks
5) X – absolutely not given during pregnancy
Pharmacotherapy of Pediatric Patient
Quick facts:
Same drugs given to adults are given to children DOSE IS SMALLER
Majority of drugs given to peds pt:
Respiratory drugs
Antibiotics
Behavioral drugs
Dose of drug is calculated by pt’s weight in kg
Pharmacokinetics of Pediatric Patient
Birth to 3-5 yr – differences present due to immature systems
3-5 yr+ - pharmacokinetics same as adult
Absorption:
, GI:
￪ stomach pH not enough HCl
￬ gastric motility, emptying, peristalsis
Tissue:
not enough BF to those areas
IM/SQ absorbed much more slowly
Skin:
￪ permeability very few layers lotions or topical can be highly toxic
Distribution:
has more water dilute many protein stores
has more fate
Liver:
less protein production ￬ chance of protein binding , ￪ chance of toxicity
Blood-brain barrier:
not mature some drug molecules can cross
Metabolism:
hepatocytes and CYP450 system not mature until age 3-5
slower metabolism
￪ risk for toxicity due to half life of drug being so high
Excretion:
kidneys and nephrons not mature
excretion of drug is limited ￪ risk of toxicity
Pediatric Considerations: Medication Administration – actual admin is determined by age
infants
toddlers
preschoolers
school-age
adolescents
Medication Safety in Pediatric Patient
Drug dosages – dramatically lower than adults, weight based
Adverse reactions – nonverbal, behaviors, crying, grimacing
Adherence – dependent on caregivers some unfortunately does not consider child’s
needs before their own
Pharmacotherapy of Geriatric Patient
Quick facts:
Polypharmacy – biggest concern
drug-drug interactions
getting multiple prescriptions filled at different pharmacy
Physiological changes – effects pharmacokinetics
Pharmacotherapy – lower dose, ￬ frequency, “start low and go slow”
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller kuglin. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R233,80. You're not tied to anything after your purchase.
